Form 10-Q BG Medicine, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
BG Medicine (BGMD) Reports Q3 Loss of $0.27/Share
November 17, 2015 7:52 AM ESTBG Medicine (: BGMD) reported Q3 EPS of ($0.27), versus ($0.28) reported last year. Revenue for the quarter came in at $334 million, versus $695 million reported last year.
Our operating results in the third quarter of 2015 reflect our ongoing efforts to extend our cash runway through the... More



